GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (LIM:TMO) » Definitions » Net Change in Cash

Thermo Fisher Scientific (LIM:TMO) Net Change in Cash : $2,019 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Thermo Fisher Scientific Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Thermo Fisher Scientific's Net Change in Cash for the three months ended in Mar. 2024 was $-2,578 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was $2,019 Mil.

Thermo Fisher Scientific Net Change in Cash Historical Data

The historical data trend for Thermo Fisher Scientific's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thermo Fisher Scientific Net Change in Cash Chart

Thermo Fisher Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 305.00 7,914.00 -5,845.00 4,046.00 -440.00

Thermo Fisher Scientific Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5,037.00 -347.00 3,015.00 1,929.00 -2,578.00

Thermo Fisher Scientific Net Change in Cash Calculation

Thermo Fisher Scientific's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=8406+-5142+-3622+-82
=-440

Thermo Fisher Scientific's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=1251+-2030+-1821+22
=-2,578

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,019 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Thermo Fisher Scientific Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Thermo Fisher Scientific's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Thermo Fisher Scientific (LIM:TMO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thermo Fisher Scientific Inc (LIM:TMO) » Definitions » Net Change in Cash
Comparable Companies
DHR IQV IDXX A MTD ICLR ILMN WAT LH DGX XSWX:LONN SHSE:603259 XPAR:BIM RVTY MEDP CRL XPAR:ERF NTRA EXAS QGEN
Traded in Other Exchanges
TMO:USA TMO:Mexico TN8:Germany TMOS34:Brazil TMO:Argentina
Address
168 Third Avenue, Waltham, MA, USA, 02451
Website
https://www.thermofisher.com
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2023 (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (10%); life science solutions (24%); and lab products and services, which includes CRO services (54%).